financetom
Business
financetom
/
Business
/
Exodus Movement Swings to Q1 Loss, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exodus Movement Swings to Q1 Loss, Revenue Increases
May 26, 2025 6:17 AM

04:52 PM EDT, 05/12/2025 (MT Newswires) -- Exodus Movement ( EXOD ) reported a Q1 loss Monday of $0.45 per diluted Class A share, compared with earnings of $1.75 a year earlier.

Two analysts polled by FactSet expected earnings of $0.07 per share.

Revenue for the quarter ended March 31 was $36 million, up from $29.1 million a year earlier.

Analysts surveyed by FactSet expected $37.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing-Lockheed JV Successfully Launches 2nd Vulcan Centaur Rocket Certification Flight
Boeing-Lockheed JV Successfully Launches 2nd Vulcan Centaur Rocket Certification Flight
Oct 4, 2024
12:32 PM EDT, 10/04/2024 (MT Newswires) -- Boeing ( BA ) and Lockheed Martin ( LMT ) joint venture United Launch Alliance said it successfully launched on Friday its second certification flight of the advanced Vulcan Centaur rocket from Cape Canaveral Space Force Station. The alliance said it had a bullseye rocket insertion in the Cert-2 mission, completing all requirements...
National Bank on DRI Healthcare's Casgevy Stream Acquisition
National Bank on DRI Healthcare's Casgevy Stream Acquisition
Oct 4, 2024
12:31 PM EDT, 10/04/2024 (MT Newswires) -- DRI Healthcare announced on October 3 that it acquired a portion of Editas Medicine payment rights under a non-exclusive license to Vertex Pharmaceuticals of Editas' Cas9 gene-editing technology for Casgevy for US$57 million. Casgevy is the only approved gene-edited cell therapy for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT), and is...
Market Chatter: GSK, Sanofi, CSL Awarded $72 Million From US Government to Boost Bird Flu Vaccine Production
Market Chatter: GSK, Sanofi, CSL Awarded $72 Million From US Government to Boost Bird Flu Vaccine Production
Oct 4, 2024
12:58 PM EDT, 10/04/2024 (MT Newswires) -- GSK (GSK), Sanofi ( SNY ) , and CSL Ltd. were awarded $72 million by the US government to increase bird flu vaccine production, Bloomberg reported Friday, citing an interview with Dawn O'Connell, assistant secretary for preparedness and response at the US Department of Health and Human Services. The funding will be used...
What's Going On With ZIM Shares Friday?
What's Going On With ZIM Shares Friday?
Oct 4, 2024
ZIM Integrated Shipping Services Ltd ( ZIM ). stock is moving lower on Friday after the International Longshoremen’s Association, the union that advocates for U.S. dockworkers currently on strike, suspended its strike until January 15. The Details: The strike resulted in operations coming to a halt at many ports on the eastern seaboard along with the Gulf Coast. The union...
Copyright 2023-2026 - www.financetom.com All Rights Reserved